2 hammered ASX shares to buy before they rise again: Celeste

If you're purchasing a house you'd want it for the lowest price. So why is it any different for stocks?

| More on:
A older man and younger man rest, exhausted but happy after a good boxing session.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you want to buy a car, you try to look for the best price. 

Who in their right mind would want to pay $50,000 if they can purchase the same vehicle for $40,000?

So it's irrational when investors are put off by ASX shares that have recently plunged in price.

If the business behind it is sound and has an exciting future, short-term discounting in the stock price should present a golden buying opportunity.

With this in mind, the analysts at Celeste Funds Management recently named two stocks in its portfolio that had a pretty ordinary December:

Still a quality company 

Shares for cooling systems provider PWR Holdings Ltd (ASX: PWH) have done outstandingly in the past year while most other stocks have struggled.

The stock price has rocketed more than 38% upwards over the last 12 months.

However, it detracted from the Celeste portfolio as 2022 ended, dipping a painful 8% in December.

Created with Highcharts 11.4.3PWR Holdings PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

In a memo to clients, the Celeste team noted that the Christmas fall came after a strong November rally on the back of its yearly financial results.

"While there were no new trading updates over the period, the stock was supported by a strong FY22 result that saw NPAT of $20.8 million (+23.9% vs pcp), 6.5% ahead of consensus expectations."

The analysts are "mindful" of how the share price has risen in recent times, but reckon more good times are ahead.

"We believe the committed order book, a strong balance sheet and the growth optionality in emerging technologies will underwrite earnings momentum over the near term."

Post-COVID recovery expected

Pathology services provider Australian Clinical Labs Ltd (ASX: ACL) watched in horror as its shares crashed 12.1% in December.

A longer timeframe doesn't do it any favours either, with the stock halving in value over the past 12 months.

The Celeste team attributed the disastrous showing to two factors.

"The first is revenue generated from COVID testing. With Australia well into the endemic phase of COVID-19, the number of COVID tests and government funding for those tests has declined precipitously," the memo read.

"This should not have come as a surprise, but consensus estimates have been slow to come down."

Created with Highcharts 11.4.3PWR Holdings PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The second issue is the recovery in "business-as-usual" (BAU) pathology tests. 

"While testing rates have recovered from pandemic lows, the recovery has been slower than expected across the industry," the Celeste team stated.

"In part this has been driven by increased telehealth consultations and in part by staff/patient absenteeism."

It's this second business that the Celeste analysts are hanging their hats on.

"As the endemic phase of COVID-19 annualises, we expect BAU testing to recover to well above pre-COVID levels."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PWR Holdings. The Motley Fool Australia has positions in and has recommended PWR Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Cheap Shares

Broker working with share prices on computers.
Cheap Shares

Why UBS thinks Magellan shares could deliver a 15% return in the next year

The broker is excited about this stock.

Read more »

Happy work colleagues give each other a fist pump.
Cheap Shares

Morgans names 2 cheap ASX 200 shares to buy

The leading broker thinks these shares are being undervalued by the market.

Read more »

Happy couple looking at a phone and waiting for their flight at an airport.
Cheap Shares

2 ASX 300 shares to buy this month: experts

These stocks could be leading opportunities according to one expert.

Read more »

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop2
Cheap Shares

Is this beaten-up stock the best value buy in the ASX 200?

An expert has outlined why this stock is an attractive opportunity.

Read more »

A woman smiles as she sits on the bus using her phone and listening to music through headphones.
Cheap Shares

2 compelling ASX shares on sale right now

These businesses look like low-priced opportunities.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Cheap Shares

2 ASX shares that I rate as cheap buys after the market rally

I still rate these stocks as bargain buys after shares recovered from April’s sell-off.

Read more »

A woman sits in a quiet home nook with her laptop computer and a notepad and pen on the table next to her as she smiles at information on the screen.
Cheap Shares

Is it time to buy these 2 beaten-up ASX shares in 2025?

I’m bullish about these two ASX shares that have gone through a sell-off.

Read more »

Two workers on site discuss the next stage of this civil engineering job, one points his hands upwards.
Cheap Shares

2 ASX 200 shares this fund manager thinks are trading at great value

These large industry players are good value.

Read more »